Skip to main content Accessibility help
×
Home
Hostname: page-component-59b7f5684b-9m8n8 Total loading time: 1.493 Render date: 2022-09-28T20:14:43.921Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "displayNetworkTab": true, "displayNetworkMapGraph": false, "useSa": true } hasContentIssue true

Chapter 3 - The Importance of Inborn Errors of Metabolism for Movement Disorders

from Section I - General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders

Published online by Cambridge University Press:  24 September 2020

Darius Ebrahimi-Fakhari
Affiliation:
Harvard Medical School
Phillip L. Pearl
Affiliation:
Harvard Medical School
Get access

Summary

Movement disorders can present a diagnostic challenge, particularly those with onset at an early age as one component of a complex neurodevelopmental disorder. With advances in next-generation sequencing technologies, the number of genes associated with movement disorders has been rapidly increasing over the last few years. Some of these genes encode transport proteins or enzymes within well-characterized metabolic pathways and their abnormal function results in disorders defined as inborn errors of metabolism (IEMs). Although individually rare, IEMs have a collective estimated incidence of 1:800 to 1:2,500 live births [1]. Movement disorders are a common symptom in IEMs affecting the central nervous system [2]. In general, movement disorders are not the sole symptom of these disorders, but are more often part of complex phenotypes that include other neurological and systemic signs and symptoms. The ability to recognize IEMs is crucial for clinicians evaluating patients presenting with movement disorders, as some IEMs are amenable to therapy, including specific dietary therapies or supplementation with vitamins, minerals, or cofactors that can prevent intoxication or treat deficiencies [3].

Type
Chapter
Information
Movement Disorders and Inherited Metabolic Disorders
Recognition, Understanding, Improving Outcomes
, pp. 26 - 42
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sanderson, S, Green, A, Preece, MA, Burton, H. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child. 2006;91(11):896–9.CrossRefGoogle ScholarPubMed
Gouider-Khouja, N, Kraoua, I, Benrhouma, H, Fraj, N, Rouissi, A. Movement disorders in neuro-metabolic diseases. Eur J Paediatr Neurol. 2010;14(4):304–7.CrossRefGoogle ScholarPubMed
Jinnah, HA, Albanese, A, Bhatia, KP, et al. Treatable inherited rare movement disorders. Mov Disord. 2018;33(1):2135.Google ScholarPubMed
Marras, C, Lang, A, van de Warrenburg, BP, et al. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force. Mov Disord. 2016;31(4):436–57.CrossRefGoogle ScholarPubMed
El Euch-Fayache, G, Bouhlal, Y, Amouri, R, Feki, M, Hentati, F. Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency. Brain. 2014;137(Pt 2):402–10.Google ScholarPubMed
Lee, J, Hegele, RA. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: A framework for diagnosis and management. J Inherit Metab Dis. 2014;37(3):333–9.Google ScholarPubMed
Albanese, A, Bhatia, K, Bressman, SB, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013;28(7):863–73.CrossRefGoogle ScholarPubMed
Wijemanne, S, Jankovic, J. Dopa-responsive dystonia: Clinical and genetic heterogeneity. Nat Rev Neurol. 2015;11(7):414–24.CrossRefGoogle ScholarPubMed
Gitiaux, C, Roze, E, Kinugawa, K, et al. Spectrum of movement disorders associated with glutaric aciduria type 1: A study of 16 patients. Mov Disord. 2008;23(16):2392–7.CrossRefGoogle ScholarPubMed
Kolker, S, Valayannopoulos, V, Burlina, AB, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: The evolving clinical phenotype. J Inherit Metab Dis. 2015;38(6):1059–74.Google ScholarPubMed
Martikainen, MH, Ng, YS, Gorman, GS, et al. Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease. JAMA Neurol. 2016;73(6):668–74.CrossRefGoogle ScholarPubMed
Ng, J, Heales, SJ, Kurian, MA. Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders. Paediatr Drugs. 2014;16(4):275–91.CrossRefGoogle ScholarPubMed
Jinnah, HA, Visser, JE, Harris, JC, et al. Delineation of the motor disorder of Lesch–Nyhan disease. Brain. 2006;129(Pt 5):1201–17.CrossRefGoogle ScholarPubMed
Mercimek-Mahmutoglu, S, Stoeckler-Ipsiroglu, S, Adami, A, et al. GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis. Neurology. 2006;67(3):480–4.Google Scholar
Allen, NM, Lin, JP, Lynch, T, King, MD. Status dystonicus: A practice guide. Dev Med Child Neurol. 2014;56(2):105–12.CrossRefGoogle ScholarPubMed
Sanger, TD, Chen, D, Fehlings, DL, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25(11):1538–49.CrossRefGoogle ScholarPubMed
Crossman, AR. Functional anatomy of movement disorders. J Anat. 2000;196 (Pt 4):519–25.CrossRefGoogle ScholarPubMed
Munchau, A. Transient (benign) infantile chorea – a physiological phenomenon during motor development? International Symposium on Pediatric Movement Disorders. Barcelona: The Movement Disorder Society; 2004.Google Scholar
Klepper, J, Leiendecker, B, Eltze, C, Heussinger, N. Paroxysmal nonepileptic events in Glut1 deficiency. Mov Disord Clin Pract. 2016;3(6):607–10.CrossRefGoogle ScholarPubMed
Keogh, MJ, Morris, CM, Chinnery, PF. Neuroferritinopathy. Int Rev Neurobiol. 2013;110:91123.CrossRefGoogle ScholarPubMed
Postuma, RB, Berg, D, Stern, M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–601.CrossRefGoogle ScholarPubMed
Di Meo, I, Tiranti, V. Classification and molecular pathogenesis of NBIA syndromes. Eur J Paediatr Neurol. 2018;22(2):272–84.CrossRefGoogle ScholarPubMed
Ebrahimi-Fakhari, D, Hildebrandt, C, Davis, PE, et al. The spectrum of movement disorders in childhood-onset lysosomal storage diseases. Mov Disord Clin Pract. 2018;5(2):149–55.CrossRefGoogle ScholarPubMed
Garcia-Cazorla, A, Duarte, ST. Parkinsonism and inborn errors of metabolism. J Inherit Metab Dis. 2014;37(4):627–42.CrossRefGoogle ScholarPubMed
Ghaoui, R, Sue, CM. Movement disorders in mitochondrial disease. J Neurol. 2018;265(5):1230–40.CrossRefGoogle ScholarPubMed
Sidransky, E, Nalls, MA, Aasly, JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med. 2009;361(17):1651–61.CrossRefGoogle ScholarPubMed
Bhatia, KP, Bain, P, Bajaj, N, et al. Consensus statement on the classification of tremors from the Task Force on Tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018;33(1):7587.CrossRefGoogle ScholarPubMed
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012;56(3):671–85.Google Scholar
Tilikete, C, Desestret, V. Hypertrophic olivary degeneration and palatal or oculopalatal tremor. Front Neurol. 2017;8:302.CrossRefGoogle ScholarPubMed
Mink, JW, Augustine, EF, Adams, HR, Marshall, FJ, Kwon, JM. Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol. 2013;28(9):1101–5.CrossRefGoogle ScholarPubMed
Ferreira, CR, Gahl, WA. Lysosomal storage diseases. Transl Sci Rare Dis. 2017;2(1–2):171.Google ScholarPubMed
Leach, EL, Shevell, M, Bowden, K, Stockler-Ipsiroglu, S, van Karnebeek, CD. Treatable inborn errors of metabolism presenting as cerebral palsy mimics: Systematic literature review. Orphanet J Rare Dis. 2014;9:197.CrossRefGoogle ScholarPubMed
Rosenbaum, P, Paneth, N, Leviton, A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:814.Google ScholarPubMed
Kolker, S, Christensen, E, Leonard, JV, et al. Diagnosis and management of glutaric aciduria type I: Revised recommendations. J Inherit Metab Dis. 2011;34(3):677–94.CrossRefGoogle ScholarPubMed
Alfadhel, M, Almuntashri, M, Jadah, RH, et al. Biotin-responsive basal ganglia disease should be renamed biotin–thiamine-responsive basal ganglia disease: A retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis. 2013;8:83.CrossRefGoogle ScholarPubMed
Pons, R, Collins, A, Rotstein, M, Engelstad, K, De Vivo, DC. The spectrum of movement disorders in Glut-1 deficiency. Mov Disord. 2010;25(3):275–81.CrossRefGoogle ScholarPubMed
Castiglioni, C, Verrigni, D, Okuma, C, et al. Pyruvate dehydrogenase deficiency presenting as isolated paroxysmal exercise induced dystonia successfully reversed with thiamine supplementation. Case report and mini-review. Eur J Paediatr Neurol. 2015;19(5):497503.CrossRefGoogle ScholarPubMed
Darras, BT, Ampola, MG, Dietz, WH, Gilmore, HE. Intermittent dystonia in Hartnup disease. Pediatr Neurol. 1989;5(2):118–20.CrossRefGoogle ScholarPubMed
Carecchio, M, Schneider, SA, Chan, H, et al. Movement disorders in adult surviving patients with maple syrup urine disease. Mov Disord. 2011;26(7):1324–8.CrossRefGoogle ScholarPubMed
Slow, EJ, Lang, AE. Oculogyric crises: A review of phenomenology, etiology, pathogenesis, and treatment. Mov Disord. 2017;32(2):193202.CrossRefGoogle Scholar
Watson, MS, Mann, MY, Lloyd-Puryear, MA, Rinaldo, P, Howell, RR.Executive summary. Genet Med. 2006;8:1S.CrossRefGoogle Scholar
Therrell, BL, Padilla, CD, Loeber, JG, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015;39(3):171–87.CrossRefGoogle ScholarPubMed
Neveling, K, Feenstra, I, Gilissen, C, et al. A post-hoc comparison of the utility of Sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat. 2013;34(12):1721–6.CrossRefGoogle Scholar
van Egmond, ME, Lugtenberg, CHA, Brouwer, OF, et al. A post hoc study on gene panel analysis for the diagnosis of dystonia. Mov Disord. 2017;32(4):569–75.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×